SHANNON SHELLENHAMER: Open Payments
NPI 1013352624 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 55 payments from 12 companies in 2025. Trend: 2023 $847 · 2024 $1,360 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $471 |
| Amgen Inc. | 11 | $139 |
| Lilly USA, LLC | 5 | $94 |
| Novo Nordisk Inc | 4 | $89 |
| ABBVIE INC. | 3 | $52 |
| Esperion Therapeutics, Inc. | 3 | $50 |
| PFIZER INC. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Boston Scientific Corporation | 1 | $27 |
| Exact Sciences Corporation | 1 | $21 |
Products named: AIRSUPRA, OTEZLA, FARXIGA, MOUNJARO, NEXLETOL, ELIQUIS, WATCHMAN Access System, REPATHA.
Industry payments across VA — which companies pay providers there.
